SFX by Ex Libris Inc.

Title:	Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection
Source:	Science [0036-8075] Zhao, Z S yr:1998

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Panet, A. "Tropism of Herpes Simplex Virus type 1 to non-melanoma skin cancers." British journal of dermatology 164.2 (2010): 273-281.
description	2.	Kaner, R J. "Fibroblast growth factor receptor is a portal of cellular entry for herpes simplex virus type 1." Science 248.4961 (1990): 1410-1413.
description	3.	Mathis, D. "Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?" Nature Immunology 2.9 (2001): 797-801.
description	4.	Schwimmbeck P L, P L. "Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus." The journal of clinical investigation 84.4 (1989): 1174-1180.
description	5.	Baker, D J J. "Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population." Journal of clinical microbiology 39.9 (2001): 3321-5.
description	6.	Hemminki, A. "Safety of Glucocorticoids in Cancer Patients Treated with Oncolytic Adenoviruses." Molecular pharmaceutics (2010): 93-103.
description	7.	Corey, L. "The acquisition of herpes simplex virus during pregnancy." The New England journal of medicine 337.8 (1997): 509-15.
description	8.	Hong, Fredrik E. "Pathophysiology and immunological profile of myasthenia gravis and its subgroups." Current opinion in immunology. 49: 9-13.
description	9.	Jing, F. "Lack of Epstein-Barr virus infection in Chinese myasthenia gravis patients." Acta neurologica Scandinavica 128.5 (2013): 345-350.
description	10.	Cavalcante, P. "The thymus in myasthenia gravis: Site of “innate autoimmunity”?" Muscle & nerve 44.4 (2011): 467-484.
description	11.	Guo, L. "Herpes simplex virus 1 ICP22 inhibits the transcription of viral gene promoters by binding to and blocking the recruitment of P-TEFb." PLoS ONE 7.9 (2012).
description	12.	Leinweber, B. "Concurrence of erythema migrans and herpes simplex: first description of a highly unusual dual skin infection." Journal of the European Academy of Dermatology and Venereology 23.4 (2009): 452-454.
description	13.	Valins, W. "The expression of toll-like receptors in dermatological diseases and the therapeutic effect of current and newer topical toll-like receptor modulators." The Journal of aesthetic and clinical dermatology 3.9 (2010): 20-29.
description	14.	Dickmanns, A. "The kinetics of simian virus 40-induced progression of quiescent cells into S phase depend on four independent functions of large T antigen." Journal of virology 68.9 (1994): 5496-5508.
description	15.	Jacobsen, H. "Progression of early steps of human immunodeficiency virus type 1 replication in the presence of an inhibitor of viral protease." Journal of virology 66.8 (1992): 5087-5091.
description	16.	D'Souza, G. "Oral sexual behaviors associated with prevalent oral human papillomavirus infection." The journal of infectious diseases 199.9 (2009): 1263-9.
description	17.	McMurray, K. "Hepatitis C virus infection and autoimmunity." Seminars in arthritis and rheumatism 26.4 (1997): 689-701.
description	18.	Sansonetti, Philippe J J. "The innate signaling of dangers and the dangers of innate signaling." Nature immunology 7.12 (2007): 1237-42.
description	19.	Cayrol, R. "Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system." Nature immunology 9.2 (2008): 137-45.
description	20.	Gilmore, W. "The risk of relapses in multiple sclerosis during systemic infections." Neurology 67.4 (2006): 652-9.